Royal Bank of Canada’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2K | Buy |
+687
| New | +$2.33K | ﹤0.01% | 6690 |
|
|
2024
Q2 | – | Sell |
-19
| Closed | – | – | 7193 |
|
|
2024
Q1 | $0 | Sell |
19
-10,500
| -100% | -$20.9K | ﹤0.01% | 7169 |
|
|
2023
Q4 | $32K | Buy |
10,519
+10,474
| +23,276% | +$27.7K | ﹤0.01% | 6162 |
|
|
2023
Q3 | $0 | Buy |
45
+14
| +45% | +$96 | ﹤0.01% | 7215 |
|
|
2023
Q2 | $0 | Buy |
+31
| New | +$307 | ﹤0.01% | 7368 |
|
|
2022
Q4 | – | Sell |
-9
| Closed | – | – | 7366 |
|
|
2022
Q3 | $0 | Sell |
9
-18
| -67% | -$270 | ﹤0.01% | 7560 |
|
|
2022
Q2 | $0 | Sell |
27
-300
| -92% | -$4.45K | ﹤0.01% | 7465 |
|
|
2022
Q1 | $7K | Sell |
327
-817
| -71% | -$22.4K | ﹤0.01% | 7106 |
|
|
2021
Q4 | $43K | Buy |
1,144
+649
| +131% | +$28.9K | ﹤0.01% | 6446 |
|
|
2021
Q3 | $24K | Buy |
495
+168
| +51% | +$8.2K | ﹤0.01% | 6607 |
|
|
2021
Q2 | $18K | Buy |
327
+2
| +0.6% | +$121 | ﹤0.01% | 6617 |
|
|
2021
Q1 | $17K | Sell |
325
-38
| -10% | -$2.14K | ﹤0.01% | 6513 |
|
|
2020
Q4 | $17K | Buy |
363
+357
| +5,950% | +$15.5K | ﹤0.01% | 6132 |
|
|
2020
Q3 | $0 | Buy |
+6
| New | +$306 | ﹤0.01% | 6717 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 6894 |
|
|
2018
Q4 | $0 | Sell |
1
-60
| -98% | -$1K | ﹤0.01% | 6857 |
|
|
2018
Q3 | $1K | Buy |
+61
| New | +$1.95K | ﹤0.01% | 6592 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | – | – | 6587 |
|
|
2018
Q1 | $0 | Sell |
1
-1
| -50% | -$63 | ﹤0.01% | 6465 |
|
|
2017
Q4 | $0 | Sell |
2
-193
| -99% | -$11.4K | ﹤0.01% | 6629 |
|
|
2017
Q3 | $13K | Buy |
195
+189
| +3,150% | +$12.7K | ﹤0.01% | 6167 |
|
|
2017
Q2 | $0 | Sell |
6
-79
| -93% | -$4.67K | ﹤0.01% | 6615 |
|
|
2017
Q1 | $5K | Sell |
85
-221
| -72% | -$9.89K | ﹤0.01% | 6210 |
|
|
2016
Q4 | $12K | Buy |
306
+173
| +130% | +$6.47K | ﹤0.01% | 6007 |
|
|
2016
Q3 | $6K | Sell |
133
-74
| -36% | -$3.15K | ﹤0.01% | 5918 |
|
|
2016
Q2 | $8K | Buy |
207
+74
| +56% | +$3.45K | ﹤0.01% | 5809 |
|
|
2016
Q1 | $6K | Sell |
133
-12
| -8% | -$506 | ﹤0.01% | 5877 |
|
|
2015
Q4 | $6K | Buy |
145
+5
| +4% | +$210 | ﹤0.01% | 6097 |
|
|
2015
Q3 | $5K | Buy |
+140
| New | +$6.54K | ﹤0.01% | 6156 |
|
|
2013
Q4 | – | Sell |
-230
| Closed | -$24K | – | 5976 |
|
|
2013
Q3 | $24K | Buy |
+230
| New | +$28.2K | ﹤0.01% | 5103 |
|
Other funds holding FBIO
OM
VCM
SAM
GCP
BCM
Royal Bank of Canada's FBIO Position: Q1 2026 in Review
Royal Bank of Canada opened a new position in Fortress Biotech (FBIO) in Q1 2026: 687 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #6690 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in FBIO as recently as Q1 2024.
Royal Bank of Canada first reported a position in FBIO in Q3 2013 and has held it in 28 quarters since. The position peaked at $43K in Q4 2021. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.
- Royal Bank of Canada held 687 shares of Fortress Biotech worth $2K as of Q1 2026.
- Fortress Biotech was a new Royal Bank of Canada position in Q1 2026.
- Fortress Biotech made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6690 holding.
- Royal Bank of Canada first reported a position in Fortress Biotech in Q3 2013 and has held it in 28 quarters since.
- Royal Bank of Canada's Fortress Biotech position peaked at $43K in Q4 2021.
- 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.